MTVA
MTVA
NASDAQ · Biotechnology

Metavia Inc

$1.82
+0.09 (+5.20%)
As of Feb 8, 2:31 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +336.8% upside
Low Target $5.82
Average Target $7.95
High Target $9.13
Current Price $1.82
Current
$1.82
Target
$7.95
$5.82 $7.95 avg $9.13
Scenario Analysis
Bear Case
$5.82
219.8%
Low target
Base Case
$7.95
+336.8%
Avg target
Bull Case
$9.13
+401.6%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$7.72
-76.4% from high
52-Week Low
$5.61
+-67.6% from low
Target vs 52W High
$7.95
+3.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%